Noel, J.; Jouinot, A.; Alexandre, J.; Ulmann, G.; Bretagne, M.; Castel-Ajgal, Z.; De Percin, S.; Vaquin-Villeminey, C.; Revel, M.-P.; Peyromaure, M.;
et al. Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers 2022, 14, 3214.
https://doi.org/10.3390/cancers14133214
AMA Style
Noel J, Jouinot A, Alexandre J, Ulmann G, Bretagne M, Castel-Ajgal Z, De Percin S, Vaquin-Villeminey C, Revel M-P, Peyromaure M,
et al. Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers. 2022; 14(13):3214.
https://doi.org/10.3390/cancers14133214
Chicago/Turabian Style
Noel, Johanna, Anne Jouinot, Jérôme Alexandre, Guillaume Ulmann, Marie Bretagne, Zahra Castel-Ajgal, Sixtine De Percin, Clémentine Vaquin-Villeminey, Marie-Pierre Revel, Michael Peyromaure,
and et al. 2022. "Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab" Cancers 14, no. 13: 3214.
https://doi.org/10.3390/cancers14133214
APA Style
Noel, J., Jouinot, A., Alexandre, J., Ulmann, G., Bretagne, M., Castel-Ajgal, Z., De Percin, S., Vaquin-Villeminey, C., Revel, M.-P., Peyromaure, M., Boudou-Rouquette, P., Arrondeau, J., Gataa, I., Durand, J.-P., Goldwasser, F., & Huillard, O.
(2022). Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers, 14(13), 3214.
https://doi.org/10.3390/cancers14133214
